Search Results 101-110 of 17936 for crohns disease
Esophageal Crohn's disease (ECD) is a rare, aggressive form of inflammatory bowel disease (IBD). Patients with ECD often present with inflammation, ...
The purpose of this study is to evaluate the effectiveness, safety and tolerability of TD-1473 in subjects with moderately-to-severely active Crohn's Disease ...
Twenty adult patients (age 18 years or older) with refractory, complicated perianal fistulizing Crohn's disease will be enrolled. Subjects will undergo ...
Have active Crohn's disease, defined as a baseline Crohn Disease Activity Index (CDAI) score of ≥ 220 and ≤ 450, with confirmation of active inflammation ...
... Crohn's disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.
A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment.
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
... Crohn's disease (CD). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
... Crohn's disease. Autologous means these cells to coat the plug come from the patient. Participation eligibility. Participant eligibility includes age, gender ...
About this study. The purpose of study is to test the effects of an experimental medication GED-0301 (mongersen) in patients who have active Crohn's disease ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.